低25OHD在内膜异位症-风险因素或后果? 这是一个巨大的惊喜!
N Abesadze1, J Kristesashvili1, A Gvenetadze1
1Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Georgia.
Georgian medical news
|October 23, 2024
概括
患有子宫内膜异位症的女性表现出较低的25-维生素D (25OHD) 和较高的活性维生素D (1,25OHD) 和水平. 手术切除子宫内膜异位症使这些维生素D代谢物和水平正常化.
科学领域:
- 内分泌学 在内分泌学.
- 妇科 妇科医生 妇科
- 代谢研究研究 代谢研究
背景情况:
- 在子宫内膜活性维生素D (1,25OHD) 可能在子宫内膜异位症中升高.
- 维生素D代谢物 (25OHD,1,25OHD) 和子宫内膜异位症中的水平需要进一步调查.
研究的目的:
- 为了确定维生素D在子宫内膜异位症发病过程中的作用.
- 分析子宫内膜异位症治疗前后的25OHD,1,25OHD和水平.
主要方法:
- 对维生素D代谢物和水平进行比较分析.
- 在手术前和手术后3个月的测量后的拉巴洛斯科比.
- 对子宫内膜异位症患者和健康对照人群进行比较.
主要成果:
- 子宫内膜异位症患者的25OHD较低,1,25OHD较高,含量高于对照组.
- 子宫内膜异位症阶段和子宫内膜瘤大小与25OHD负相关.
- 手术后,1,25OHD和减少,而25OHD显著增加.
结论:
- 子宫内膜异位症与维生素D代谢的改变 (低25OHD,高1,25OHD) 和高血症有关.
- 升高的1,25OHD表明子宫内膜异位症的转化增加,可能是由高需求驱动的.
- 手术干预会影响维生素D代谢物水平,这表明子宫内膜异位症会影响其调节.
更多相关视频
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
15.9K
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
14.0K
相关概念视频
Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
Disorders of the Female Reproductive System
332
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
332
Infertility in Females
288
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
288
Ovarian Cycle
1.0K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.0K
Hormonal Regulation of the Menstrual Cycle
308
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
308
Menopause
143
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
143
